{name}
{subtitle}
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
city
~45 mi. (Homewood, Alabama, +314 more cities)
facility
Urology Centers Of Alabama
biomarker
ATM Loss, +61 more biomarkers
drug
abiraterone, +2 more drugs
drug type
hormone therapy, +1 more type
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)
city
~47 mi. (Birmingham, Alabama, +144 more cities)
facility
The University of Alabama at Birmingham ( Site 0010)
drug
belzutifan, +3 more drugs
drug type
immunotherapy, +1 more type
A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma
city
~47 mi. (Birmingham, Alabama, +133 more cities)
facility
University of Alabama at Birmingham
drug
bortezomib, +4 more drugs
drug type
chemotherapy, +3 more types